| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10917931 | Radiotherapy and Oncology | 2015 | 6 Pages |
Abstract
We confirm the utility of CLR1404 for tumor imaging and treatment of HNC. This promising agent warrants further investigation in a developing phase I trial combining 131I-CLR1404 with reduced-dose external beam radiation in patients with loco-regionally recurrent HNC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Zachary S. Morris, Jamey P. Weichert, Jarob Saker, Eric A. Armstrong, Abigail Besemer, Bryan Bednarz, Randall J. Kimple, Paul M. Harari,